127 / 182
FIVE
| 123
Integrated Report 2016
ANNUAL FINANCIAL STATEMENTS
(continued)
SIX
THREE
ONE
FOUR
TWO
2016
R’000
2015
R’000
Capital expenditure
(2)
Continuing operations
Southern Africa
56 252
42 002
OTC
17 427
3 730
Consumer
274
176
Prescription
8 369
8 867
Hospital
30 182
29 229
Rest of Africa
1 700
8 640
India
–
287
Other – shared services
33 142
28 935
91 094
79 864
Discontinued operations
India
777
–
Rest of Africa (Ghana)
3 571
–
4 348
–
(2)
Capital expenditure consists of additions to property, plant and equipment, but excludes additions to intangible assets.
OTHER
Impairments
(3)
Continuing operations
Southern Africa
3 437
479
Prescription
3 149
–
Hospital
288
479
Rest of Africa
–
–
Other – shared services
5 201
5 857
8 638
6 336
Discontinued operations
India
135 012
74 432
Rest of Africa (Ghana)
72 959
7 390
207 971
81 822
Depreciation and amortisation
Continuing operations
Southern Africa
92 152
87 956
OTC
39 629
35 401
Consumer
8 439
9 281
Prescription
15 860
14 223
Hospital
28 224
29 051
Rest of Africa
4 589
3 657
Research and development services in India
918
940
Other – shared services
48 782
42 909
146 441
135 462
Discontinued operations
India
–
58 065
Rest of Africa (Ghana)
1 624
2 571
1 624
60 636
(3)
Impairments include impairments of long-term receivables, intangible assets, property, plant and equipment and assets held-for-sale.